Barclays Maintains Overweight on Xylem, Lowers Price Target to $156

Xylem Inc. -0.12%

Xylem Inc.

XYL

119.88

-0.12%

Barclays analyst William Grippin maintains Xylem (NYSE: XYL) with a Overweight and lowers the price target from $166 to $156.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via